AI English summary of an SEC filing — figures as filed
Colgate-Palmolive CLColgate-Palmolive said net sales for the quarter ended September Q3 increased 2.0% to $5,131 million, organic sales rose 0.4% and diluted earnings per share were $0.91. The company said organic sales included a 0.8% negative impact from lower private label pet sales as it exited that non-strategic business.
Key points
AI summaryColgate-Palmolive said net sales for the quarter ended September Q3 increased 2.0% to $5,131 million, organic sales rose 0.4% and diluted earnings per share were $0.91. The company said organic sales included a 0.8% negative impact from lower private label pet sales as it exited that non-strategic business.
The company said GAAP gross profit margin for the quarter ended Q3 fell 170 basis points to 59.4%. Operating profit for Q3 was $1,059 million with an operating profit margin of 20.6%, compared with $1,065 million and 21.2% in the prior-year quarter.
Colgate-Palmolive updated its organic sales growth guidance for full year 2025 to 1% to 2%, versus the low end of 2% to 4% previously. The company said this includes an approximately 70 basis points impact from its exit from private label pet sales.
The company said its Board of Directors approved on July 31, 2025 a 3-year Strategic Growth and Productivity Program with estimated cumulative pre-tax charges of $200 million to $300 million. It said approximately 75% to 85% of the charges will result in cash expenditures and substantially all charges will be incurred by December 31, 2028.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q3 Net Sales, Organic Sales and Earnings Per Share
Colgate-Palmolive said net sales for the quarter ended September Q3 increased 2.0% to $5,131 million, organic sales rose 0.4% and diluted earnings per share were $0.91. The company said organic sales included a 0.8% negative impact from lower private label pet sales as it exited that non-strategic business.
Source · Based on the filing body and exhibits
Q3 Gross Profit Margin and Operating Profit
The company said GAAP gross profit margin for the quarter ended Q3 fell 170 basis points to 59.4%. Operating profit for Q3 was $1,059 million with an operating profit margin of 20.6%, compared with $1,065 million and 21.2% in the prior-year quarter.
Source · Based on the filing body and exhibits
2025 Full-Year Organic Sales Growth Guidance
Colgate-Palmolive updated its organic sales growth guidance for full year 2025 to 1% to 2%, versus the low end of 2% to 4% previously. The company said this includes an approximately 70 basis points impact from its exit from private label pet sales.
Source · Based on the filing body and exhibits
Strategic Growth and Productivity Program Estimated Charges
The company said its Board of Directors approved on July 31, 2025 a 3-year Strategic Growth and Productivity Program with estimated cumulative pre-tax charges of $200 million to $300 million. It said approximately 75% to 85% of the charges will result in cash expenditures and substantially all charges will be incurred by December 31, 2028.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…